Literature DB >> 10098436

Place of radiotherapy in the treatment of Graves' orbitopathy.

V Beckendorf1, T Maalouf, J L George, P Bey, J Leclere, E Luporsi.   

Abstract

PURPOSE: The aim of this study is to evaluate the response of Graves' orbitopathy to irradiation, and to specify the prognostic factors allowing one to better define the indications of orbital radiotherapy. METHODS AND MATERIALS: From 1977 to 1996, 199 patients received bilateral orbital irradiation delivering 20 Gy in 10 fractions and 2 weeks for a progressive Graves' orbitopathy. 195 patients were seen between 1 and 6 months after radiotherapy. The different symptoms were studied and their response to radiation was analyzed. Factors such as age, sex, evolution of thyroid disease, history of symptoms, and previous or combined treatments were analyzed.
RESULTS: The results revealed that 50 patients (26%) had a good or excellent response, 98 (50%) had a partial response, 37 (19%) were stable, 10 (5%) had a progression of disease. The signs that best responded to radiotherapy were the infiltration of soft tissues and the corneal involvement. Responses of proptosis or oculomotor disorders were more complete when these signs were not advanced at the time of treatment. Irradiation seemed to have the same efficacy when applied as first-line treatment or after failure of corticosteroids. Neither modality of treatment of hyperthyroidism nor thyroid status at the time of orbital irradiation modified the results. The best results were recorded for early or moderately advanced presentation (p = 0.05). Patients treated within a delay of 7 months after the beginning of the ophthalmopathy had better responses than patients treated later (p = 0.10).
CONCLUSION: Radiation therapy was successful in Graves' orbitopathy by stopping the progression of disease in almost all cases, by improving the comfort of patients, by obtaining objective responses, and by avoiding surgical treatments particularly when signs were moderate.

Entities:  

Mesh:

Year:  1999        PMID: 10098436     DOI: 10.1016/s0360-3016(98)00405-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

Review 1.  Does radiotherapy have a role in the management of thyroid orbitopathy? View 1.

Authors:  Kimberley P Cockerham; John S Kennerdell
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

2.  Improvement of the MRI and clinical features of Asian Graves' ophthalmopathy by radiation therapy with steroids.

Authors:  Zichang Ma; Hiroshi Ozaki; Yojiro Ishikawa; Keiichi Jingu
Journal:  Jpn J Radiol       Date:  2019-06-14       Impact factor: 2.374

Review 3.  The effect of orbital radiation therapy on thyroid-associated orbitopathy complicated with dysthyroid optic neuropathy.

Authors:  Yang Wang; Huifang Zhou; Xianqun Fan
Journal:  Front Med       Date:  2017-05-13       Impact factor: 4.592

4.  Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous?

Authors:  L Bartalena; C Marcocci; C A Gorman; W M Wiersinga; A Pinchera
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

5.  Clinical outcomes of radiotherapy as initial local therapy for Graves' ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery.

Authors:  Roshan S Prabhu; Lang Liebman; Ted Wojno; Brent Hayek; William A Hall; Ian Crocker
Journal:  Radiat Oncol       Date:  2012-06-19       Impact factor: 3.481

6.  Thyroid eye disease survey: An anonymous web-based survey in the Indian subcontinent.

Authors:  Anuradha Pradhan; Anasua Ganguly; Milind N Naik; Akshay Gopinathan Nair; Savari Desai; Suryasnata Rath
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

7.  Low- vs. high-dose radiotherapy in Graves' ophthalmopathy: a retrospective comparison of long-term results.

Authors:  Thomas Weissmann; Sebastian Lettmaier; Anna-Jasmina Donaubauer; Christoph Bert; Manfred Schmidt; Friedrich Kruse; Oliver Ott; Markus Hecht; Rainer Fietkau; Benjamin Frey; Florian Putz
Journal:  Strahlenther Onkol       Date:  2021-04-16       Impact factor: 4.033

8.  Clinical outcomes of hypofractionated radiotherapy for thyroid-associated ophthalmopathy.

Authors:  Sang Min Lee; Jung Ho Im; Hyun Soo Shin; Helen Lew
Journal:  BJR Open       Date:  2020-09-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.